LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Petites molécules dans la polyarthrite rhumatoïde.

    Verdon, Aurore / Lauper, Kim

    Revue medicale suisse

    2020  Volume 16, Issue 685, Page(s) 477–480

    Abstract: If treatment target is not reached with a conventional disease-modifying antirheumatic drug (csDMARD) such as methotrexate in rheumatoid arthritis, it is recommended to use a biologic (bDMARD) or a Janus kinase (JAK) inhibitor, small synthetic molecules ... ...

    Title translation Small molecules treatment in rheumatoid arthritis.
    Abstract If treatment target is not reached with a conventional disease-modifying antirheumatic drug (csDMARD) such as methotrexate in rheumatoid arthritis, it is recommended to use a biologic (bDMARD) or a Janus kinase (JAK) inhibitor, small synthetic molecules recently developed. Oral administration and short half-life can favour the choice of JAK inhibitors, as well as the opportunity to use it in monotherapy, even though co-treatment with csDMARD is recommended. As yet long-term studies are lacking, little is known about adverse effects although risk of herpes virus infections is clearly higher with JAK inhibitors than bDMARD treatments.
    MeSH term(s) Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/chemistry ; Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/drug therapy ; Drug Therapy, Combination ; Humans ; Janus Kinase Inhibitors/administration & dosage ; Janus Kinase Inhibitors/adverse effects ; Janus Kinase Inhibitors/chemistry ; Janus Kinase Inhibitors/therapeutic use ; Methotrexate/therapeutic use ; Treatment Outcome
    Chemical Substances Antirheumatic Agents ; Janus Kinase Inhibitors ; Methotrexate (YL5FZ2Y5U1)
    Language French
    Publishing date 2020-03-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Lupus érythémateux systémique et Covid-19.

    Verdon, Aurore / Zanisi, Laura / Melong Pianta, Cathy / Iudici, Michele

    Revue medicale suisse

    2021  Volume 17, Issue 729, Page(s) 487–490

    Abstract: This article synthesizes the main aspects of the management of systemic lupus erythematosus patients in the context of the COVID-19 pandemic based on published literature. We will therefore develop on topics such as the risk of getting infected, the ... ...

    Title translation Systemic Lupus Erythematosus and COVID-19.
    Abstract This article synthesizes the main aspects of the management of systemic lupus erythematosus patients in the context of the COVID-19 pandemic based on published literature. We will therefore develop on topics such as the risk of getting infected, the differences in COVID-19 clinical course and severity compared to general population, the role of antiphospholipid antibodies in thrombotic complications, and treatment strategies.
    MeSH term(s) Antiphospholipid Syndrome/diagnosis ; Antiphospholipid Syndrome/therapy ; COVID-19 ; Humans ; Lupus Erythematosus, Systemic ; Pandemics ; SARS-CoV-2
    Language French
    Publishing date 2021-03-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top